BRIEF-Crescita Therapeutics Q4 Net Loss Per Share $0.59

1 分钟阅读

March 28 (Reuters) - Crescita Therapeutics Inc:

* CRESCITA THERAPEUTICS REPORTS 2017 FOURTH QUARTER AND YEAR END RESULTS

* QTRLY NET LOSS PER SHARE FROM CONTINUING OPERATIONS $0.59

* QTRLY REVENUE C$2.4 MILLION VERSUS C$2.2 MILLION

* CASH AND CASH EQUIVALENTS WERE $7.0 MILLION AS AT DECEMBER 31, 2017 COMPARED TO $9.8 MILLION AS AT DECEMBER 31, 2016 Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below